Corbus Pharmaceuticals Holdings, Inc.
CRBPAs of the close on Sep 25, 2026
Price
$7.14
Market cap
$138M
P/E (diluted TTM)
—
A per-share figure for one of the last four quarters is not shown, so no four-quarter total is given
EPS (TTM)
—
A per-share figure for one of the last four quarters is not shown, so no four-quarter total is given
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How Corbus Pharmaceuticals Holdings, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Source: Corbus Pharmaceuticals Holdings, Inc. — 10-K filed Mar 7, 2023
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 13 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 11, 2026. The latest institutional report shown is dated Jun 30, 2025; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| StoneX Group Inc. | 2022-12-31 | 13,106 | Not shown | SEC filing |
- Each value is checked against Corbus Pharmaceuticals Holdings, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 1 row: no share price from within three months of its report date is on file, so it could not be checked.
- 5 rows left out: they repeat the same share count and value quarter after quarter, which a market value cannot do.
1 filer has only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Corbus Pharmaceuticals Holdings, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-02-13 · Cohen Yuval: Larger than 27 of the 29 other insider sales of Common Stock, par value $0.0001 per share on file. SEC filing
- 2025-10-24 · Cohen Yuval: Larger than all 29 other insider sales of Common Stock, par value $0.0001 per share on file. SEC filing
- 2024-09-20 · Cormorant Asset Management, LP: Larger than 50 of the 55 other insider purchases of Common Stock on file. SEC filing
- 2024-09-20 · Cormorant Asset Management, LP: Larger than 53 of the 55 other insider purchases of Common Stock on file. SEC filing
- 2024-06-14 · Cohen Yuval: Larger than 28 of the 29 other insider sales of Common Stock, par value $0.0001 per share on file. SEC filing
- 2024-03-08 · Cormorant Asset Management, LP: Larger than 54 of the 55 other insider purchases of Common Stock on file. SEC filing
- 2024-03-07 · Cormorant Asset Management, LP: Larger than 51 of the 55 other insider purchases of Common Stock on file. SEC filing
- 2024-03-07 · Cormorant Asset Management, LP: Larger than 52 of the 55 other insider purchases of Common Stock on file. SEC filing
- 2024-02-02 · Cormorant Asset Management, LP: Larger than all 55 other insider purchases of Common Stock on file. SEC filing
Independent insiders buying near the same time
- 2022-08-10–2022-08-10: 3 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
- 2022-05-16–2022-05-16: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2022-03-09–2022-03-10: 3 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
- 2020-03-17–2020-03-17: 4 event(s) across 4 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing )
- 2019-11-11–2019-11-12: 4 event(s) across 4 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing )
- 2019-08-12–2019-08-15: 5 event(s) across 4 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing )
- 2019-05-13–2019-05-17: 3 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-10 | Altmeyer Anne · Director | Common Stock, par value $0.0001 per share | S — Open market or private sale | −2,412 | 7.91 | SEC filing |
| 2026-06-10 | Jenkins John Kenneth · Director | Common Stock, par value $0.0001 per share | S — Open market or private sale | −4,800 | 7.91 | SEC filing |
| 2026-06-10 | Kung Winston · Director | Common Stock, par value $0.0001 per share | S — Open market or private sale | −2,026 | 7.91 | SEC filing |
| 2026-06-03 | Saxena Nishant C · Chief Business Officer | Common Stock, par value $0.0001 per share | P — Open market or private purchase | +9,000 | 7.58 | SEC filing |
| 2026-06-02 | Saxena Nishant C · Chief Business Officer | Common Stock, par value $0.0001 per share | P — Open market or private purchase | +4,500 | 7.33 | SEC filing |
| 2026-03-02 | Smethurst Dominic · Chief Medical Officer | Common Stock, par value $0.0001 per share | S — Open market or private sale | −6,097 | 8.30 | SEC filing |
| 2026-02-17 | Hodgson Ian · Chief Operating Officer | Common Stock, par value $0.0001 per share | S — Open market or private sale | −847 | 7.38 | SEC filing |
| 2026-02-13 | Moran Sean F. · Chief Financial Officer | Common Stock, par value $0.0001 per share | S — Open market or private sale | −4,701 | 7.78 | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-05-21 | Saxena Nishant C · Chief Business Officer | Stock options (right to buy) | A — Grant, award, or other acquisition | +192,300 | SEC filing |
| 2026-05-21 | Saxena Nishant C · Chief Business Officer | Common Stock, par value $0.0001 per share | A — Grant, award, or other acquisition | +58,300 | SEC filing |
| 2026-05-19 | Kung Winston · Director | Stock options (right to buy) | A — Grant, award, or other acquisition | +12,300 | SEC filing |
| 2026-05-19 | Altmeyer Anne · Director | Stock options (right to buy) | A — Grant, award, or other acquisition | +12,300 | SEC filing |
| 2026-05-19 | Pfeiffenberger Brent · Director | Stock options (right to buy) | A — Grant, award, or other acquisition | +24,700 | SEC filing |
| 2026-05-19 | Ben Yong · Director | Common Stock, par value $0.0001 per share | A — Grant, award, or other acquisition | +3,800 | SEC filing |
| 2026-05-19 | Jenkins John Kenneth · Director | Stock options (right to buy) | A — Grant, award, or other acquisition | +12,300 | SEC filing |
| 2026-05-19 | Jacques Rachelle Suzanne · Director | Stock options (right to buy) | A — Grant, award, or other acquisition | +12,300 | SEC filing |
Showing 8 of 20 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.